GLS and cancer: Thus, the Fe–S biogenesis pathway represents a critical vulnerability in cancer cells that may be exploited via redox manipulation with pro-oxidants (e.g., AscH−), iron chelation (e.g., DFX), or iron mimicry (e.g., GaM).